Abstract
More than 2,500 researchers, clinicians, laboratorians, veterinarians, and other public health professionals from all 50 states and more than 70 countries convened in Atlanta on March 8-11, 1998, for the International Conference on Emerging Infectious Diseases. The conference, organized by the Centers for Disease Control and Prevention (CDC), the Council of State and Territorial Epidemiologists, the American Society for Microbiology, and the National Foundation for CDC along with 62 other cosponsors,1 provided a forum for the exchange of ideas and possible solutions to the problems of new and reemerging infectious diseases, including potential threats presented by bioterrorism. Several agencies and organizations sponsored satellite partnership meetings on March 8 and March 12. More than 85 sessions (12 plenary sessions, 17 invited panels, 35 poster sessions, and latebreaking abstracts) were presented on surveillance, epidemiology, prevention, and control of emerging infectious diseases, as well as emergency preparedness and response and reemerging or drug-resistant infectious diseases. Topics included foodborne diseases, infectious diseases transmitted by animals and insects, nosocomial infections, infections in immunocompromised patients and persons outside the health-care system, infectious causes of chronic disease, blood safety, host genetics, vaccines, global climate change, and immigration and travel. In delivering the keynote address, Nobel laureate Joshua Lederberg reviewed the scientific basis for the emergence of infectious diseases. U.S. Health and Human Services Secretary Donna Shalala and Assistant Secretary for Health and Surgeon General David Satcher, along with representatives from the World Health Organization, the Pan American Health Organization, and the U.S. Agency for International Development, and representatives from academia and industry addressed the national and international ramifications of emerging infections. In closing the conference, James Hughes, director, National Center for Infectious Diseases, CDC, stressed the importance of building bridges and forging new partnerships to prevent and control the emergence of infections into the next millennium. In publishing the conference presentations and discussions in this journal, the organizers hope to capture the energy expressed by all participants, further disseminate new information on emerging infections, and stimulate more research and other initiatives against this important public health threat. About the International Conference on Emerging Infectious Diseases
Highlights
These findings demonstrate low genetic diversity among Y132F isolates from the same country
76.7% (23/30) of patients with Y132F isolates had no antifungal exposure within 30 days before candidemia detection, and their clonal transmission was not detected by routine hospital surveillance, partly because more than half of the patient hospitalizations did not overlap. These findings indicate that clonal Y132F isolates may be dormant over long periods and can survive and persist outside their host on hospital environmental surfaces, which may be similar to the behavior of C. auris [10]
We describe a case of B. miyamotoi disease in an immunocompetent patient in western Europe
Summary
We describe an abdominal AGI caused by M. chimaera and Granulicatella adiacens. The objective of our study was to describe the characteristics of pediatric patients who had atypical or severe forms of the disease and to search for predictive factors for severe forms. The purpose of this study was to investigate and report 3 unusual cases of arboviral disease that occurred in Colorado in 2008. Based on the need for information about this aspect, we aimed to determine the diffusion of mcr-1–driven colistin resistance in the hospital environment
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
